TLR8: The forgotten relative revindicated

Cellular and Molecular Immunology

Volumn 9, Issue 6, 2012, Pages 434-438

  Cervantes, Jorge L ^a   Weinerman, Bennett ^a   Basole, Chaitali ^a   Salazar, Juan C ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Farmington   (United States)

Author keywords

Human monocytes; TLR8; Type I interferon

Indexed keywords

BACTERIAL RNA; BETA INTERFERON; CYTOKINE; DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; NUCLEIC ACID; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR;

AUTOIMMUNITY; CELL VACUOLE; DENDRITIC CELL; ENDOSOME; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTE; PHAGOSOME; REVIEW; RNA SPLICING;

ALTERNATIVE SPLICING; ANIMALS; ENDOSOMES; HUMANS; MODELS, IMMUNOLOGICAL; RNA, BACTERIAL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 8;

BACTERIA (MICROORGANISMS); MUS;

EID: 84868598029     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2012.38     Document Type: Review

References (64)

1. Barton GM, Kagan JC. A cell biological view of Toll-like receptor function: Regulation through compartmentalization. Nat Rev Immunol 2009; 9: 535-542.
2. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216. (Pubitemid 34293424)
3. Kawai T, Akira S. The role of pattern-Recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol 2010; 11: 373-384.
4. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801. (Pubitemid 43261452)
5. Kawai T, Akira S. TLR signaling. Cell Death Differ 2006; 13: 816-825.
6. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-650.
7. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30: 16-34.
8. Jin T, Perry A, Jiang J, Smith P, Curry JA, Unterholzner L et al. Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 2012; 36: 561-571.
9. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009; 458: 514-518.
10. Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, Wagner H et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002; 3: 499. (Pubitemid 34669818)
11. Davila S, Hibberd ML, Hari Dass R, Wong HE, Sahiratmadja E, Bonnard C et al. Genetic association and expression studies indicate a role of Toll-like receptor 8 in pulmonary tuberculosis. Plos Genet 2008; 4: E1000218.
12. Gantier MP, Irving AT, Kaparakis-Liaskos M, Xu D, Evans VA, Cameron PU et al. Genetic modulation of TLR8 response following bacterial phagocytosis. Hum Mutat 2010; 31: 1069-1079.
13. Cervantes JL, Dunham-Ems SM, la Vake CJ, Petzke MM, Sahay B, Sellati TJ et al. Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-Beta. Proc Natl Acad Sci USA 2011; 108: 3683-3688.
14. Cervantes JL, la Vake CJ, Salazar JC. Human TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytes. Cytokine [Abstract]. 2011; 56: 107.
15. Gantier MP, Tong S, Behlke MA, Xu D, Phipps S, Foster PS et al. TLR7 is involved in sequence-specific sensing of single-stranded RNAs in human macrophages. J Immunol 2008; 180: 2117-2124.
16. Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010; 32: 305-315.
17. Gringhuis SI, van der Vlist M, van den Berg LM, den Dunnen J, Litjens M, Geijtenbeek TB. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat Immunol 2010; 11: 419-426.
18. Gorden KB, Gorski KS, Gibson SJ, Kedl RM, Kieper WC, Qiu X et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005; 174: 1259-1268.
19. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S et al. Speciesspecific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526-9. (Pubitemid 38314424)
20. Guo Z, Garg S, Hill KM, Jayashankar L, MoOney MR, Hoelscher M et al. A distal regulatory region is required for constitutive and IFN-Beta-induced expression of murine TLR9 gene. J Immunol 2005; 175: 7407-7418. (Pubitemid 41713438)
21. Alexopoulou L, Desnues B, Demaria O. [Toll-like receptor 8: The awkward TLR]. Med Sci (Paris) 2012; 28: 96-102.
22. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168: 4531-4537. (Pubitemid 34441357)
23. Rajagopal R, Waller AS, Mendoza JD, Wightman PD. The covalent modification and regulation of TLR8 in HEK-293 cells stimulated with imidazoquinoline agonists. Biochem J 2008; 409: 275-287.
24. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1 delivers nucleotidesensing toll-like receptors to endolysosomes. Nature 2008; 452: 234-238. (Pubitemid 351380247)
25. Itoh H, Tatematsu M, Watanabe A, Iwano K, Funami K, Seya T et al. UNC93B1 physically associates with human TLR8 and regulates TLR8-mediated signaling. Plos One 2011; 6: E28500.
26. Mancuso G, Gambuzza M, Midiri A, Biondo C, Papasergi S, Akira S et al. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol 2009; 10: 587-594.
27. Eberle F, Sirin M, Binder M, Dalpke AH. Bacterial RNA is recognized by different sets of immunoreceptors. Eur J Immunol 2009; 39: 2537-2547.
28. Kariko K, Buckstein M, Ni H, Weissman D. Suppression ofRNArecognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005; 23: 165-175. (Pubitemid 41169286)
29. Salazar JC, Duhnam-Ems S, la Vake C, Cruz AR, Moore MW, Caimano MJ et al. Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-Beta. Plos Pathog 2009; 5: E1000444.
30. Boo KH, Yang JS. Intrinsic cellular defenses against virus infection by antiviral type I interferon. Yonsei Med J 2010; 51: 9-17.
31. Jockel S, Nees G, Sommer R, Zhao Y, Cherkasov D, Hori H et al. The 29-O-methylation status of a single guanosine controls transfer RNA-mediated Toll-like receptor 7 activation or inhibition. J Exp Med 2012; 209: 235-241.
32. Zhu J, Lai K, Brownile R, Babiuk LA, Mutwiri GK. Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod. Mol Immunol 2008; 45: 3238-3243.
33. Forsbach A, Nemorin JG, Montino C, Muller C, Samulowitz U, Vicari AP et al. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J Immunol 2008; 180: 3729-3738.
34. Gorden KK, Qiu XX, Binsfeld CC, Vasilakos JP, Alkan SS. Cutting edge: Activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides. J Immunol 2006; 177: 6584-6587. (Pubitemid 44715019)
35. Martinez J, Huang X, Yang Y. Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA. Proc Natl Acad Sci USA 2010; 107: 6442-6447.
36. Bauer S, Bathke B, Lauterbach H, Patzold J, Kassub R, Luber CA et al. A major role for TLR8 in the recognition of vaccinia viral DNA by murine pDC? Proc Natl Acad Sci USA 2010; 107: E139; author reply E40.
37. Ghosh TK, Mickelson DJ, Solberg JC, Lipson KE, Inglefield JR, Alkan SS. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha. Int Immunopharmacol 2007; 7: 1111-1121. (Pubitemid 46891328)
38. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-Polarizing program in dendritic cells. Nat Immunol 2005; 6: 769-776. (Pubitemid 43090462)
39. Makela SM, Strengell M, Pietila TE, Osterlund P, Julkunen I. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J Leukoc Biol 2009; 85: 664-672.
40. Schwarz H, Posselt G, Wurm P, Ulbing M, Duschl A, Horejs-Hoeck J. TLR8 and NOD signaling synergistically induce the production of IL-1beta and IL-23 in monocytederived DCs and enhance the expression of the feedback inhibitor SOCS2. Immunobiology 2012.
41. Mureith MW, Chang JJ, Lifson JD, Ndung9u T, Altfeld M. Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Tolllike receptor 2/4 ligands. AIDS 2010; 24: 1841-8.
42. Hackstein H, Knoche A, Nockher A, Poeling J, Kubin T, JurkMet al. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation. Cell Immunol 2011; 271: 401-412.
43. Sellati TJ, Bouis DA, Caimano MJ, Feulner JA, Ayers C, Lien E et al. Activation of human monocytic cells by Borrelia burgdorferi and TrepOnema pallidum is facilitated by CD14 and correlates with surface exposure of spirochetal lipoproteins. J Immunol 1999; 163: 2049-2056. (Pubitemid 29382209)
44. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999; 285: 736-739.
45. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, Wooten RM et al. Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999; 163: 2382-2386. (Pubitemid 29399155)
46. Daud II, Scott ME, Ma Y, Shiboski S, Farhat S, Moscicki AB. Association between tolllike receptor expression and human papillomavirus type 16 persistence. Int J Cancer 2011; 128: 879-886.
47. Wang J, Shao Y, Bennett TA, Shankar RA, Wightman PD, Reddy LG. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. J Biol Chem 2006; 281: 37427-37434. (Pubitemid 46042046)
48. Demaria O, Pagni PP, Traub S, de Gassart A, Branzk N, Murphy AJ et al. TLR8 deficiency leads to autoimmunity in mice. J Clin Invest 2010; 120: 3651-3662.
49. Zheng L, Zhang Z, Yu C, Yang C. Expression of Toll-like receptors 7, 8, and 9 in primary Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 844-850.
50. Chuang TH, Ulevitch RJ. Cloning and characterization of a sub-family of human tolllike receptors: HTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 2000; 11: 372-378. (Pubitemid 32268894)
51. Du X, Poltorak A, Wei Y, Beutler B. Three novel mammalian toll-like receptors: Gene structure, expression, and evolution. Eur Cytokine Netw 2000; 11: 362-371. (Pubitemid 32268893)
52. Oh DY, Taube S, Hamouda O, Kucherer C, Poggensee G, Jessen H et al. A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis 2008; 198: 701-709.
53. Ziegler-Heitbrock L. The CD141CD161 blood monocytes: Their role in infection and inflammation. J Leukoc Biol 2007; 81: 584-592. (Pubitemid 46393535)
54. Connolly DJ, O'Neill LA. New developments in Toll-like receptor targeted therapeutics. Curr Opin Pharmacol 2012; 12: 510-518.
55. Tomai MA, Miller RL, Lipson KE, Kieper WC, Zarraga IE, Vasilakos JP. Resiquimod and other immune response modifiers as vaccine adjuvants. Expert Rev Vaccines 2007; 6: 835-847. (Pubitemid 47607857)
56. Du J, Wu Z, Ren S, Wei Y, Gao M, Randolph GJ et al. TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity. Vaccine 2010; 28: 6273-6281.
57. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007; 13: 552-559. (Pubitemid 46830615)
58. Lu H, Dietsch GN, Matthews MA, Yang Y, Ghanekar S, InokumaMet al. VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. Clin Cancer Res 2012; 18: 499-509.
59. Horak F. VTX-1463, a novel TLR8 agonist for the treatment of allergic rhinitis. Expert Opin Investig Drugs 2011; 20: 981-986.
60. Wille-Reece U, Flynn BJ, Lore K, Koup RA, Kedl RM, Mattapallil JJ et al. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD81 T cell responses in nonhuman primates. Proc Natl Acad Sci USA 2005; 102: 15190-15194. (Pubitemid 41513357)
61. Nian H, Geng WQ, Cui HL, Bao MJ, Zhang ZN, Zhang M et al. R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes. BMC Infect Dis 2012; 12: 5.
62. Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, RyffelBet al. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 2011; 474: 385-389.
63. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327: 291-295.
64. Hurst J, von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun Rev 2008; 7: 204-208